繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Quantum Bizerma重新获得纳斯达克合规性

2024-09-09 13:35

  • Quantum BioPharma (NASDAQ:QNTMreceived Nasdaq notice stating that the company has regained compliance with the minimum bid price requirement.
  • The company is now in compliance with all applicable listing standards and will continue to be listed and traded on the Nasdaq.
  • In addition, the company has completed debt settlements in the amount of $450K with each of Anthony Durkacz, Zeeshan Saeed and Donal Carroll, officers of the company. 

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。